Hydrogenology
Source-linked study record

Effect of hydrogen/oxygen therapy for ordinary COVID-19 patients: a propensity-score matched case-control study

Zeng Y, Guan W, Wang K, Jie Z, Zou X, Tan X, Li X, Chen X, Ren X, Jiang J, Zheng Z, Shi J, Zhong N. · BMC Infectious Diseases. 2023;23:440.

HumanInhaled H₂Published 2023Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Human

Population or model

Adults hospitalized in China with ordinary, non-severe COVID-19 between December 2019 and March 2020.

Intervention and dose

Nasal-mask H₂/O₂ for at least six hours daily on more than seven consecutive days, plus standard care. · Total mixture flow was 3.0 L/min; direct 2:1 calculation gives H₂ flow 2.0 L/min and O₂ flow 1.0 L/min.

Duration

At least six hours/day for more than seven consecutive days; clinical follow-up through discharge and day-28 discharge-rate analysis.

Reported result

Matched median stay was 12 versus 13 days and later discharge rates and day-5 SpO₂ favored H₂/O₂. Day-14 discharge did not differ significantly. Gender and time from symptom onset were not associated with stay within the H₂/O₂ subgroup; no significant adverse effects were observed.

Main limitation

Retrospective nonrandomized study with small matched groups, propensity matching on only age, sex and time to admission, possible unmeasured confounding, incomplete post-treatment laboratory/SpO₂ data and early-pandemic care. Public Chinese grants were reported and authors declared no competing interests.

Evidence and classification

What kind of evidence is this?

Evidence type

Human

Reported design

Three-centre retrospective propensity-score-matched case-control study

Research topic

Respiratory health

Administration form

Inhaled H₂

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Adults hospitalized in China with ordinary, non-severe COVID-19 between December 2019 and March 2020.

Sample

180 eligible records before matching: 42 H₂/O₂ and 138 oxygen. The principal 1:2 matched analysis included 33 H₂/O₂ and 55 oxygen patients.

Duration

At least six hours/day for more than seven consecutive days; clinical follow-up through discharge and day-28 discharge-rate analysis.

Intervention

Nasal-mask H₂/O₂ for at least six hours daily on more than seven consecutive days, plus standard care.

Hydrogen form

Brown's gas / oxyhydrogen at an H₂:O₂ volume ratio of 2:1.

Dose or H₂ specification

Total mixture flow was 3.0 L/min; direct 2:1 calculation gives H₂ flow 2.0 L/min and O₂ flow 1.0 L/min.

H₂ flow

2,000 mL/min.

O₂ delivered with H₂

1,000 mL/min.

Comparator

Standard care plus low-flow air/oxygen therapy below 3.0 L/min, with duration adjusted clinically.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Hospital length of stay, discharge by days 14, 21 and 28, day-5 SpO₂, vital signs, respiratory symptoms, adverse events and mortality.

Reported result

Matched median stay was 12 versus 13 days and later discharge rates and day-5 SpO₂ favored H₂/O₂. Day-14 discharge did not differ significantly. Gender and time from symptom onset were not associated with stay within the H₂/O₂ subgroup; no significant adverse effects were observed.

Extraction completeness

The complete free PMC article and supplementary-analysis descriptions were checked for the unmatched and matched cohorts, gas ratio/flow, schedule, primary and null results, safety, funding and conflicts.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Retrospective nonrandomized study with small matched groups, propensity matching on only age, sex and time to admission, possible unmeasured confounding, incomplete post-treatment laboratory/SpO₂ data and early-pandemic care. Public Chinese grants were reported and authors declared no competing interests.

Applies directly to

Ordinary COVID-19 hospitalized during the original 2019–2020 outbreak; contemporary treatment relevance is uncertain.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 37386364 · DOI: 10.1186/s12879-023-08424-4

Publisher access

Free full article in PubMed Central.

Extraction basis

Complete PMC article, supplementary-analysis descriptions and PubMed metadata; full-text extraction checked 9 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.